Cybin (HELP) Amortization (2020 - 2024)
Cybin (HELP) reported Amortization of -$18.8 million for Q4 2024, down 44.58% on a YoY basis from -$33.8 million in Q1 2024, and down 18.62% quarter-over-quarter from -$15.8 million in Q3 2024.
Cybin (HELP) Amortization (2020 - 2024) Analysis & Trends
Cybin has reported Amortization for 5 years, with the latest figure at -$18.8 million in Q4 2024.
- For the quarter ending Q4 2024, Amortization fell 44.58% year-over-year to -$18.8 million; the trailing twelve-month figure through Dec 2024 stood at -$57.8 million (down 49.72% YoY), and the FY2023 full-year result was $1541.7, changed N/A from the prior year.
- Amortization for Q4 2024 stood at -$18.8 million, down from -$15.8 million in the prior quarter.
- The five-year high for Amortization was $20.2 million in Q1 2021, with the low at -$18.8 million in Q4 2024.
- Historically, Amortization has averaged -$6.6 million across 5 years, with a median of -$8.4 million in 2023.
- Annual changes were most pronounced in 2021 — Amortization slumped 555.47% — and 2022, when it climbed 15.46%.
- Cybin's Amortization stood at -$5.5 million in 2020, then sank by 71.72% to -$9.5 million in 2021, then rose by 15.46% to -$8.0 million in 2022, then tumbled by 62.0% to -$13.0 million in 2023, then plunged by 44.58% to -$18.8 million in 2024.
- The last three Amortization figures came in at -$18.8 million (Q4 2024), -$15.8 million (Q3 2024), and -$10.3 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18.76 Mn |
| Dec 31, 2024 | -18.76 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Feb 28, 2023 | 1,500.32 |
| Feb 28, 2023 | 1,500.32 |
| Dec 31, 2022 | -8.01 Mn |
| Dec 31, 2022 | -8.01 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Sep 30, 2022 | -8.44 Mn |
| Dec 31, 2021 | -9.47 Mn |
| Dec 31, 2021 | -9.47 Mn |